Contraindicated. Coadministration not advisable; strong cytochrome P450 enzyme inducers reduce systemic exposure to roflumilast and could decrease the therapeutic efficiencyNo dosage adjustment for ondansetron is recommended for clients on these medicine.Insignificant (one)phenobarbital will lower the level or influence of ondansetron by impacting